The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

The Global Ophthalmic Viscosurgical Devices market was valued at $705.21 million in 2024 and is projected to grow to $1.65 billion by 2034 , with a CAGR of 8.9% during the forecast period, 2024-2034.

The rationale for the study, according to the authors, is that “Nearly 2% of the US population received a prescription for ...

Ron Ofri, DVM, PhD, DECVO, shares how veterinary professionals can make eye exams easier for all during his recent lecture at ...

The Ophthalmic Surgical Knives Market is projected to grow from approximately USD 240 million in 2024 to around USD 360 million by 2031, at a compound annual growth rate (CAGR) of 5.8%. Growth is ...

Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...

Appasamy Associates has appointed Annaswamy Vaidheesh as its non-executive chairman. With over 35 years of experience in the ...

(NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its proprietary Optejet topical ophthalmic medication dispensing platform, today ...

Protheragen launches a full spectrum of ophthalmic drug preclinical R&D services to streamline the complex process of developing effective therapies for eye diseases. Protheragen, a reputable research ...